2020
DOI: 10.3390/medicina56020064
|View full text |Cite
|
Sign up to set email alerts
|

A Rare Case of Fatal Endobronchial Mucormycosis Masquerading as Endobronchial Tuberculosis

Abstract: Pulmonary mucormycosis is a relatively rare but often fatal opportunistic fungal infection that occurs mostly in immunocompromised patients. Endobronchial mucormycosis, a distinct clinical form of pulmonary mucormycosis, is very rare, and only a few cases have been reported. The most common bronchoscopic findings in patients with endobronchial mucormycosis are stenosis, erythematous mucosa and airway obstruction. Here, we present a case of fatal endobronchial mucormycosis mimicking actively caseating endobronc… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(5 citation statements)
references
References 10 publications
0
5
0
Order By: Relevance
“…They are ubiquitous and predominantly found in the soil or decaying organic matter. Infection usually occurs via the inhalation of spores with pulmonary forms occasionally mimicking the clinical presentation of pulmonary TB and may be misdiagnosed as such [ 61 , 62 , 63 , 64 ]. Usually, pulmonary mucormycosis is an acute or subacute infection, with a poor outcome, but occasionally it can be a chronic disease process.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…They are ubiquitous and predominantly found in the soil or decaying organic matter. Infection usually occurs via the inhalation of spores with pulmonary forms occasionally mimicking the clinical presentation of pulmonary TB and may be misdiagnosed as such [ 61 , 62 , 63 , 64 ]. Usually, pulmonary mucormycosis is an acute or subacute infection, with a poor outcome, but occasionally it can be a chronic disease process.…”
Section: Resultsmentioning
confidence: 99%
“…Mucormycosis should therefore be considered in patients with suspected TB, especially when there is no improvement with anti-tuberculous therapy in patients with risk factors outlined above. Mortality often occurs with delayed presentation and/or diagnosis [ 63 ]. Besides fatalities, economic losses and prolonged hospital stay are other challenges identified in the highlighted case reports and these were not unconnected with poor awareness and low index of suspicion on the part of clinicians [ 61 , 62 , 63 , 64 ].…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Cases, where lung collapse was observed on chest radiograph along with an exophytic tracheal or central airway lesion, were also included if the radiograph normalised immediately after managing tracheal mucormycosis. We excluded cases with concomitant pulmonary parenchymal involvement or tracheal infiltration secondary to mucormycosis of the adjacent structures (such as laryngeal, pharyngeal, oesophageal, mediastinal structures or vascular aneurysmal rupture into the trachea) 4–9 . We also excluded cases with lobar or segmental bronchial involvement 10–12 .…”
Section: Methodsmentioning
confidence: 99%
“…We excluded cases with concomitant pulmonary parenchymal involvement or tracheal infiltration secondary to mucormycosis of the adjacent structures (such as laryngeal, pharyngeal, oesophageal, mediastinal structures or vascular aneurysmal rupture into the trachea). [4][5][6][7][8][9] We also excluded cases with lobar or segmental bronchial involvement. [10][11][12] We excluded conference abstracts, review articles and editorials.…”
Section: Inclusion and Exclusion Criteriamentioning
confidence: 99%